Abstract
Introduction
The aim of this study was to investigate the possible correlation between peripheral blood biomarkers and morphological characteristics of retinal imaging in patients with retinal vein occlusion (RVO).
Methods
Participants in this cross-sectional observational study were 65 consecutive patients (65 eyes) with treatment-naïve RVO, who underwent spectral-domain optical coherence tomography (SD-OCT) and fundus fluorescein angiography (FFA). In addition, peripheral blood samples were taken to evaluate full blood count and biochemical parameters. The association between imaging characteristics and laboratory parameters was examined.
Results
Eyes with subretinal fluid presented significantly higher neutrophil-to-lymphocyte ratios (p = 0.028). Hyperreflective foci on SD-OCT were found to be associated with higher triglyceride levels (p = 0.024). The presence of cysts on SD-OCT was associated with significantly higher triglycerides (p = 0.010). Central subfield thickness (CST) higher than 464 μm was associated with higher lymphocyte count (p = 0.016) and higher urea (p = 0.015). No significant associations were found between laboratory parameters and intraretinal fluid, ellipsoid zone and external limiting membrane condition, or epiretinal membrane and macular ischemia.
Conclusions
Specific imaging morphological characteristics were found to be associated with laboratory parameters in patients with RVO. These findings may help reveal the pathophysiology of RVO and its correlation with the development of specific clinical signs, while they could guide individualized treatment.
Similar content being viewed by others
Explore related subjects
Find the latest articles, discoveries, and news in related topics.Avoid common mistakes on your manuscript.
Why carry out this study? |
The potential correlation between peripheral blood biomarkers and morphological characteristics of retinal imaging has been hypothesized to guide individualized treatment in patients with retinal vein occlusion (RVO). |
What was learned from the study? |
Specific imaging morphological characteristics were found to be associated with laboratory parameters in patients with RVO. |
Eyes with subretinal fluid on optical coherence tomography presented significantly higher neutrophil-to-lymphocyte ratios. |
Hyperreflective foci and the presence of cysts on optical coherence tomography were found to be significantly associated with higher triglyceride levels. |
Central subfield thickness higher than 464 μm was associated with higher lymphocyte count and higher urea. |
Introduction
Retinal vein occlusion (RVO) is the second most common retinal vascular disease after diabetic retinopathy and a significant cause of visual loss if left untreated, especially due to macular edema and retinal ischemia [1,2,3]. In 2015, the global prevalence of RVO was found to be about 0.77% in people aged 30–89 [4]. Today it is estimated that about 16 million people worldwide suffer from RVO [5].
The exact pathogenesis of RVO is not fully understood, but various cardiovascular, thrombophilic, systemic and ocular risk factors predispose to RVO, with the most common being hypertension, atherosclerosis, dyslipidemia, diabetes mellitus, smoking, hyperhomocysteinemia, hypercoagulability, ocular inflammatory diseases and open-angle glaucoma [6, 7]. Inflammation has been also implicated in the pathogenesis of RVO, since concentrations of several inflammatory mediators have been found to be elevated in patients with RVO, showing a correlation with the severity of the disease, as characterized by the presence of macular edema or ischemia [8,9,10,11].
Despite the current understanding of RVO pathogenesis and the data regarding intraocular biomarkers in RVO, literature is scarce about systemic biomarkers and their association with morphological characteristics in retinal imaging. Of note, great developments in retinal imaging are occurring nowadays, especially with the advent of spectral domain-optical coherence tomography (SD-OCT) and swept-source OCT (SS-OCT) [12, 13], as well as OCT angiography [14].
Based on the above, the purpose of the present study was to investigate the potential association between peripheral blood biomarkers and morphological characteristics of retinal imaging in patients with RVO.
Methods
Participants in this observational, cross-sectional study were 65 consecutive patients with treatment-naïve RVO, who were diagnosed and treated at 2nd Department of Ophthalmology, National and Kapodistrian University of Athens, Athens, Greece between 1 September 2019 and 31 March 2021. Diagnosis of RVO was made clinically on the basis of the presence of retinal hemorrhages, retinal vein dilatation, tortuosity, and flame-shaped and dot-blot hemorrhages, and confirmed by retinal imaging, including fundus fluorescein angiography (FFA) and SD-OCT. Patients with retinal diseases other than RVO, corneal disease, uveitis, glaucoma, dry eye disease, trauma or any previous intraocular surgery during the last 6 months were excluded from the study.
All participants underwent a complete ophthalmologic examination, including best-corrected visual acuity (BCVA) measurement by means of Snellen charts (converted to logMAR scale), slit-lamp examination, dilated fundoscopy, SD-OCT and FFA using the Spectralis imaging platform (Spectralis HRA+OCT, Heidelberg Engineering, Heidelberg, Germany), as described previously [15]. SD-OCT was obtained using a standard acquisition protocol; six radial scans 3 mm long were performed at equally spaced angular orientations centered on the foveola. The OCT volume scan was performed on a 20° × 20° cube, and consisted of 49 horizontal B-scans with 20 averaged frames per B-scan centered over the fovea [15]. The following SD-OCT variables were recorded at baseline: central subfield thickness (CST, μm) and presence of intraretinal fluid (IRF), subretinal fluid (SRF), cysts, hyperreflective foci (HF) and epiretinal membrane (ERM), while the ellipsoid zone (EZ) and external limiting membrane (ELM) condition was also assessed. Moreover, macular ischemia was evaluated on FFA and defined as disruption and enlargement of the foveal avascular zone (FAZ).
On the same day and following an 8-hour overnight fast, all patients underwent a forearm venous puncture for peripheral blood extraction and serum was separated. Full blood count was measured on a Sysmex XE-2100 analyzer (Sysmex Corp. Kobe, Japan), while all biochemical analyses were performed on a Roche Cobas 8000 (Roche, Chicago, IL, USA) in the laboratory of Attikon University Hospital [15]. Specifically, we analyzed the following parameters: glucose, glycated Hb (HbA1c), urea, creatinine, uric acid, triglycerides, lipoprotein(a), homocysteine, vitamin D, vitamin B12, folate, ferritin and ferrum. Cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), apolipoprotein A and apolipoprotein B values were not included in the analysis, since some patients received statins, which could affect the results of the study.
Statistical Analysis
For the description of patients’ characteristics, descriptive statistics were calculated; mean ± standard deviation (SD) was used for continuous variables, while relative frequencies and percentages for categorical variables were reported. All variables were tested for normal distribution with the Shapiro–Wilk test. The associations between laboratory and imaging variables were evaluated with the Mann–Whitney-Wilcoxon test (MWW), as appropriate. Statistical analysis was performed using STATA/SE 13 statistical software (Stata Corporation, College Station, TX, USA). A p value < 0.05 was considered statistically significant [15].
Compliance with Ethics Guidelines
The study protocol adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Attikon University Hospital (Reference number: 699/2019). Written informed consent to participate to the study and for publication of data was obtained by all participants before enrollment in the study.
Results
The demographic and clinical characteristics of the study sample are shown in Table 1. The mean age of patients was 67.5 ± 9.8 years; 53.8% of patients were male and 46.2% female. Forty-seven out of 65 patients (72.3%) had central RVO (CRVO) and 18 patients (27.7%) had branch RVO (BRVO). The mean BCVA was 0.78 ± 0.46 logMAR, while the mean CST was 474.2 ± 76.1 μm.
Regarding the potential association between imaging characteristics and laboratory variables, no significant correlations were found for IRF, EZ and ELM condition, or ERM and macular ischemia.
Table 2 shows the comparison of laboratory parameters between eyes with SRF (n = 30) and without SRF (n = 35). Eyes with SRF presented significantly higher neutrophil-to-lymphocyte ratios (NLR) compared to those without SRF (p = 0.028, MWW). There was no statistically significant difference for the other laboratory parameters between the two groups.
Table 3 shows the comparison of laboratory parameters between eyes with HF (n = 26) and those without HF (n = 39). Eyes with HF presented significantly higher triglyceride levels compared to eyes without HF (p = 0.024, MWW). No statistically significant differences were found for any other laboratory values between the two groups.
Table 4 shows the comparison of laboratory parameters between eyes with cysts (n = 57) and those without cysts (n = 8). Eyes with cysts had significantly higher triglyceride levels compared to eyes without cysts (p = 0.010, MWW), while all other laboratory values showed no statistically significant difference between the two groups.
Table 5 shows the comparison of laboratory parameters between eyes with CST above or equal to median (464 μm) and those with CST below median. Eyes with CST ≥ 464 μm presented higher lymphocytes (p = 0.016, MWW) and higher urea (p = 0.015, MWW) compared to eyes with CST < 464 μm. There were no statistically significant differences regarding the other laboratory parameters between the two groups.
Discussion
The principal message of the study is that most of the imaging morphological characteristics studied herein were not correlated with laboratory parameters in patients with RVO, suggesting that macular edema secondary to RVO may be mainly attributed to a local response more than a systemic effect. However, CST and specific OCT biomarkers, i.e., SRF, HF and cysts, were found to be associated with laboratory findings in patients with RVO, shedding light on the pathophysiology of RVO and its correlation with the development of these specific clinical characteristics.
Firstly, higher serum triglyceride levels were associated with the presence of HF and cysts. Many theories have attempted to explain the pathophysiology of HF, but their precise nature remains elusive. Framme et al. suggested that HF can be leucocytes or retinal pigment epithelium cells, indicating retinal inflammation [16]. Coscas et al. supported this concept and postulated that HF are microglial cells activated by inflammation [17]. Previous studies have found an association between HF and dyslipidemia, especially high levels of triglycerides in patients with diabetic macular edema, supporting the view that inflammatory reaction may be enhanced by dyslipidemia [18]. Moreover, it has been reported that metabolic syndrome and the related dyslipidemia has been involved in the development of microvascular changes in the retina, even in the absence of diabetes [19]. A similar pathogenetic mechanism could be hypothesized in patients with RVO.
Another finding of our study was that patients with SRF on SD-OCT presented with higher NLR. It is worth noting that NLR has been proposed as an indicator of inflammation in several diseases, such as coronary artery disease, non-cardiac diseases, age-related macular degeneration and diabetic retinopathy [20,21,22,23]. Furthermore, NLR has been previously evaluated in patients with RVO and found to be higher compared to controls [24,25,26]. Noma et al. demonstrated that high levels of inflammatory factors (i.e., soluble vascular endothelial growth factor receptor-2 and soluble intercellular adhesion molecule 1) were observed in patients with macular edema and serous retinal detachment secondary to CRVO, suggesting that an inflammatory component may prevail in such cases [27]. The latter can explain the significantly higher NLR in patients with SRF in our study.
In our study, we also found that higher urea was associated with more severe macular edema, with higher CST in patients with RVO. Hwang et al. found that macular edema and CST decreased significantly after initiation of dialysis in patients with chronic renal failure, since improvement in uremia occurs after dialysis [28]. Moreover, renal function has been indicated as a possible predictor for treatment response in certain patients with diabetic macular edema [29]. Finally, in patients with RVO, normal baseline renal parameters (urea and creatinine) predict better visual outcome after treatment and offer additional benefit over and above that obtained with macular edema reduction [30]. Therefore, it could be postulated that high urea is a negative predictor for macular edema in patients with RVO, as was found in our study.
A limitation of the study is that inflammation-related factors, such as C-reactive protein, interleukin and tumor necrosis factor-alpha (TNF-α), were not assessed. Further studies with a larger study sample size are needed, including analysis of these factors.
Conclusion
In conclusion, this study investigated the potential correlation between imaging morphological findings and laboratory biomarkers in patients with RVO. Our results showed that inflammatory biomarkers such as NLR, lymphocytes and urea were associated with more severe disease activity with higher CST and the presence of HF and SRF, while higher triglyceride levels were also found to be associated with the presence of HF and cysts. These findings may shed light on the pathophysiology of RVO, enhancing the view that there is an inflammatory component in RVO patients, especially in cases with specific characteristics such as HF and SRF, allowing an individualized approach in treatment decisions. However, it should be noted that most of the imaging biomarkers studied herein were not correlated with laboratory parameters in patients with RVO, suggesting that RVO may be mainly attributed to a local response more than a systemic effect. Further studies with large sample size are needed to justify our results.
References
Ip M, Hendrick A. Retinal vein occlusion review. Asia Pac J Ophthalmol. 2018;7:40–5.
Jonas JB, Monés J, Glacet-Bernard A, et al. Retinal vein occlusions. Dev Ophthalmol. 2017;58:139–67.
McIntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1113–23.
Song P, Xu Y, Zha M, et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9: 010427.
Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313–9.
Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost. 2010;8:1886–94.
Jaulim A, Ahmed B, Khanam T, et al. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature Retina. 2013;33:901–10.
Noma H, Mimura T, Tatsugawa M, et al. Aqueous flare and inflammatory factors in macular edema with central retinal vein occlusion: a case series. BMC Ophthalmol. 2013;13:78.
Noma H, Funatsu H, Harino S, et al. Vitreous inflammatory factors in macular edema with central retinal vein occlusion. Jpn J Ophthalmol. 2011;55:248–55.
Deobhakta A, Chang LK. Inflammation in retinal vein occlusion. Int J Inflam. 2013;2013: 438412.
Noma H, Yasuda K, Shimura M. Cytokines and pathogenesis of central retinal vein occlusion. J Clin Med. 2020;9:3457.
Phadikar P, Saxena S, Ruia S, et al. The potential of spectral domain optical coherence tomography imaging based retinal biomarkers. Int J Retina Vitreous. 2017;3:1.
Vira J, Marchese A, Singh RB, et al. Swept-source optical coherence tomography imaging of the retinochoroid and beyond. Expert Rev Med Devices. 2020;17:413–26.
Onishi AC, Fawzi AA. An overview of optical coherence tomography angiography and the posterior pole. Ther Adv Ophthalmol. 2019;11:2515841419840249.
Dimitriou E, Sergentanis TN, Lambadiari V, Theodossiadis G, Theodossiadis P, Chatziralli I. Correlation between imaging morphological findings and laboratory biomarkers in patients with diabetic macular edema. J Diabetes Res. 2021;2021:6426003.
Framme C, Wolf S, Wolf-Schnurrbusch U. Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51:5965–9.
Coscas G, Coscas F, Vismara S, et al. Spectral Domain OCT in age-related macular degeneration: preliminary results with Spectralis HRA-OCT. J Fr Ophtalmol. 2008;31:353–61.
Chung YR, Lee SY, Kim YH, et al. Hyperreflective foci in diabetic macular edema with serous retinal detachment: association with dyslipidemia. Acta Diabetol. 2020;57:861–6.
Wong TY, Duncan BB, Golden SH, et al. Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study. Invest Ophthalmol Vis Sci. 2004;45:2949–54.
Agarwal R, Aurora RG, Siswanto BB, et al. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis (in press). https://doi.org/10.1097/MCA.0000000000001040.
Ahsen A, Ulu MS, Yuksel S, et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation. 2013;36:1357–62.
Ilhan N, Daglioglu MC, Ilhan O, et al. Assessment of neutrophil/lymphocyte ratio in patients with age-related macular degeneration. Ocul Immunol Inflamm. 2015;23:287–90.
Ulu SM, Dogan M, Ahsen A, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther. 2013;15:942–7.
Dursun A, Ozturk S, Yucel H, et al. Association of neutrophil/lymphocyte ratio and retinal vein occlusion. Eur J Ophthalmol. 2015;25:343–6.
Şahin M, Elbey B, Şahin A, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in retinal vein occlusion. Clin Exp Optom. 2020;103:490–4.
Zhu DD, Liu X. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in branch retinal vein occlusion. J Ophthalmol. 2019;2019:6043612.
Noma H, Funatsu H, Mimura T, et al. Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case control series. J Inflamm. 2011;8:38.
Hwang H, Chae JB, Kim JY, et al. Changes in optical coherence tomography findings in patients with chronic renal failure undergoing dialysis for the first time. Retina. 2019;39:2360–8.
Hwang H, Lee H, Kim JY, et al. Systemic factors and early treatment response to intravitreal injection for diabetic macular edema; the role of renal function. Retina. 2021;41:1275–82.
Madanagopalan VG, Kumari B. Predictive value of baseline biochemical parameters for clinical response of macular edema to bevacizumab in eyes with central retinal vein occlusion: a retrospective analysis. Asia Pac J Ophthalmol. 2018;7:321–30.
Acknowledgements
Funding
No funding or sponsorship was received for this study or publication of this article.
Authorship
All authors whose names appear on the submission have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; drafted the work or revised it critically for important intellectual content; approved the version to be published; and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy of integrity of any part of the work are appropriately investigated and resolved.
Author Contributions
Dimitrios Kazantzis, Genovefa Machairoudia, Eleni Dimitriou and Christos Kroupis collected data. George Theodossiadis and Panagiotis Theodossiadis critically revised the manuscript. Theodoros Sergentanis performed the statistical analysis and critically revised the manuscript. Irini Chatziralli conceived the idea, collected data, analyzed and interpreted data, drafted the manuscript and supervised the study. All authors have read and approved the final version of the manuscript.
Disclosures
Dimitrios Kazantzis, Theodoros N. Sergentanis, Genovefa Machairoudia, Eleni Dimitriou, Christos Kroupis, George Theodossiadis, Panagiotis Theodossiadis and Irini Chatziralli have nothing to disclose.
Compliance with Ethics Guidelines
The study protocol was adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Attikon University Hospital (Reference number: 699/2019). Written informed consent to participate to the study and for publication of data was obtained by all participants before enrollment to the study.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Kazantzis, D., Sergentanis, T.N., Machairoudia, G. et al. Correlation Between Imaging Morphological Findings and Laboratory Biomarkers in Patients with Retinal Vein Occlusion. Ophthalmol Ther 12, 1239–1249 (2023). https://doi.org/10.1007/s40123-023-00677-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40123-023-00677-1